By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics has received clearance from the Canadian government to market its biomarker-based microarray test for celiac disease, which runs on its multiplex testing kit, the Toronto-based company said today.

Health Canada has given a medical device license to SQI’s IgX Plex Celiac microarray test kit, which measures four biomarkers, for use on the SQiDworks platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.